Placental exosomes as early biomarker of preeclampsia: Potential role of exosomalmicrornas across gestation

Journal of Clinical Endocrinology and Metabolism

Volumn 102, Issue 9, 2017, Pages 3182-3194

  Salomon, Carlos ^a,b,c   Guanzon, Dominic ^a   Scholz Romero, Katherin ^a   Longo, Sherri ^b   Correa, Paula ^d   Illanes, Sebastian E ^d   Rice, Gregory E ^a,b,d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b OCHSNER CLINIC FOUNDATION   (United States)

^c UNIVERSITY OF CONCEPCIÓN   (Chile)

^d UNIVERSIDAD DE LOS ANDES   (Chile)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; HSA MIR 486 1 5P; HSA MIR 486 2 5P; MICRORNA; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; CASE CONTROL STUDY; CELL ISOLATION; COHORT ANALYSIS; CONTROLLED STUDY; CORRELATIONAL STUDY; EXOSOME; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; HUMAN; HUMAN CELL; MATERNAL PLASMA; PLACENTA; POPULATION RISK; PREECLAMPSIA; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; RETROSPECTIVE STUDY; RISK FACTOR; BLOOD; INCIDENCE; METABOLISM; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; PROCEDURES; REGRESSION ANALYSIS; RISK ASSESSMENT; ROLE PLAYING;

ADULT; AREA UNDER CURVE; BIOMARKERS; COHORT STUDIES; EXOSOMES; FEMALE; GESTATIONAL AGE; HUMANS; INCIDENCE; MICRORNAS; PRE-ECLAMPSIA; PREGNANCY; PREGNANCY OUTCOME; PRENATAL DIAGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; ROLE;

EID: 85025809656     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2017-00672     Document Type: Article

References (59)

1. Kuklina EV, Ayala C, Callaghan WM. Hypertensive disorders and severe obstetric morbidity in the United States. Obstet Gynecol. 2009;113(6):1299-1306.
2. Ananth CV, Keyes KM, Wapner RJ. Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis. BMJ. 2013; 347:f6564.
3. McDonald SD, Malinowski A, Zhou Q, Yusuf S, Devereaux PJ. Cardiovascular sequelae of preeclampsia/eclampsia: a systematic review and meta-analyses. Am Heart J. 2008;156(5):918-930.
4. Bellamy L, Casas JP, Hingorani AD, Williams DJ. Pre-eclampsia and risk of cardiovascular disease and cancer in later life: systematic review and meta-analysis. BMJ. 2007;335(7627):974.
5. Valdiviezo C, Garovic VD, Ouyang P. Preeclampsia and hypertensive disease in pregnancy: their contributions to cardiovascular risk. Clin Cardiol. 2012;35(3):160-165.
6. Xiao DY, Ohlendorf J, Chen YL, Taylor DD, Rai SN, Waigel S, Zacharias W, Hao HY, McMasters KM. Identifying mRNA, microRNA, and protein profiles of melanoma exosomes. PLoS One. 2012;7(10):e46874.
7. RabinowitsG, Geŗel-Taylor C, Day JM, Taylor DD, Kloecker GH. Exosomal microRNA: a diagnostic marker for lung cancer. Clin Lung Cancer. 2009;10(1):42-46.
8. Tannetta DS, Dragovic RA, Gardiner C, Redman CW, Sargent IL. Characterisation of syncytiotrophoblast vesicles in normal pregnancy and pre-eclampsia: expression of Flt-1 and endoglin. PLoS One. 2013;8(2):e56754.
9. Mitchell MD, Peiris HN, Kobayashi M, Koh YQ, Duncombe G, Illanes SE, Rice GE, Salomon C. Placental exosomes in normal and complicated pregnancy. Am J Obstet Gynecol. 2015;213(4, Suppl) S173-S181.
10. Kalra H, Adda CG, Liem M, Ang CS, Mechler A, Simpson RJ, Hulett MD,Mathivanan S. Comparative proteomics evaluation of plasma exosome isolation techniques and assessment of the stability of exosomes in normal human blood plasma. Proteomics. 2013; 13(22):3354-3364.
11. Harding CV, Heuser JE, Stahl PD. Exosomes: looking back three decades and into the future. J Cell Biol. 2013;200(4):367-371.
12. Ha M, Kim VN. Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014;15(8):509-524.
13. Valadi H, Ekstr om K, Bossios A, Sj ostrand M, Lee JJ, Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol. 2007; 9(6):654-659.
14. Yang Q, Lu J, Wang S, Li H, Ge Q, Lu Z. Application of nextgeneration sequencing technology to profile the circulating microRNAs in the serum of preeclampsia versus normal pregnant women. Clin Chim Acta. 2011;412(23-24):2167-2173.
15. Li H, Ge Q, Guo L, Lu Z. Maternal plasma miRNAs expression in preeclamptic pregnancies. BioMed Res Int. 2013;2013:970265.
16. Wu L, Zhou H, Lin H, Qi J, Zhu C, Gao Z, Wang H. Circulating microRNAs are elevated in plasma from severe preeclamptic pregnancies. Reproduction. 2012;143(3):389-397.
17. Luque A, Farwati A, Crovetto F, Crispi F, Figueras F, Gratacós E, Aran JM. Usefulness of circulating microRNAs for the prediction of early preeclampsia at first-trimester of pregnancy. Sci Rep. 2014;4: 4882.
18. Ura B, Feriotto G, Monasta L, Bilel S, Zweyer M, Celeghini C. Potential role of circulating microRNAs as early markers of preeclampsia. Taiwan J Obstet Gynecol. 2014;53(2):232-234.
19. Gunel T, Zeybek YG, Aķakaya P, Kaleliǒ glu I, Benian A, Ermis H, Aydinli K. Serum microRNA expression in pregnancies with preeclampsia. Genet Mol Res. 2011;10(4):4034-4040.
20. Hromadnikova I, Kotlabova K, Doucha J, Dlouha K, Krofta L. Absolute and relative quantification of placenta-specific micrornas in maternal circulation with placental insufficiency-related complications. J Mol Diagn. 2012;14(2):160-167.
21. Murphy MS, Casselman RC, Tayade C, Smith GN. Differential expression of plasma microRNA in preeclamptic patients at delivery and 1 year postpartum. Am J Obstet Gynecol. 2015;213(3): 367.e1-367.e9.
22. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H, Sun S. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med. 2012;16(2):249-259.
23. Cheng L, Sharples RA, Scicluna BJ, Hill AF. Exosomes provide a protective and enriched source of miRNA for biomarker profiling compared to intracellular and cell-free blood. J Extracell Vesicles. 2014;3:3.
24. Salomon C, Scholz-Romero K, Sarker S, Sweeney E, Kobayashi M, Correa P, Longo S, DuncombeG,MitchellMD, Rice GE, Illanes SE. Gestational diabetes mellitus is associated with changes in the concentration and bioactivity of placenta-derived exosomes in maternal circulation across gestation. Diabetes. 2016;65(3): 598-609.
25. Sarker S, Scholz-Romero K, Perez A, Illanes SE, Mitchell MD, Rice GE, Salomon C. Placenta-derived exosomes continuously increase in maternal circulation over the first trimester of pregnancy. J Transl Med. 2014;12:204.
26. Salomon C, Torres MJ, Kobayashi M, Scholz-Romero K, Sobrevia L, Dobierzewska A, Illanes SE, Mitchell MD, Rice GE. A gestational profile of placental exosomes in maternal plasma and their effects on endothelial cell migration. PLoS One. 2014;9(6):e98667.
27. Salomon C, Ryan J, Sobrevia L, Kobayashi M, Ashman K, Mitchell M, Rice GE. Exosomal signaling during hypoxia mediates microvascular endothelial cell migration and vasculogenesis. PLoS One. 2013;8(7):e68451.
28. Salomon C, KobayashiM, Ashman K, Sobrevia L,Mitchell MD, Rice GE. Hypoxia-induced changes in the bioactivity of cytotrophoblastderived exosomes. PLoS One. 2013;8(11):e79636.
29. Salomon C, Scholz-Romero K, Kobayashi M, Smith M, Duncombe G, Hanes S, Mitchell MD, Rice GE. Oxygen tension regulates glucose-induced biogenesis and release of different subpopulations of exosome vesicles from trophoblast cells: a gestational age profile of placental exosomes in maternal plasma with gestational diabetes mellitus. Placenta. 2015;36:488.
30. Cartwright JE, Keogh RJ, Tissot van Patot MC. Hypoxia and placental remodelling. Adv Exp Med Biol. 2007;618:113-126.
31. Mackowiak SD. Identification of novel and known miRNAs in deep-sequencing data with miRDeep2. Curr Protoc Bioinformatics. 2011;12:12.10.
32. Kozomara A, Griffiths-Jones S. miRBase: annotating high confidence microRNAs using deep sequencing data. Nucleic Acids Res. 2014;42(D1):D68-D73.
33. Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.
34. Friedman J, Hastie T, Tibshirani R. Additive logistic regression: a statistical view of boosting. Ann Stat. 2000;28:337-374.
35. Lötvall J, Hill AF, Hochberg F, Buzás EI, Di Vizio D, Gardiner C, Gho YS, Kurochkin IV, Mathivanan S, Quesenberry P, Sahoo S, Tahara H, Wauben MH, Witwer KW, Théry C. Minimal experimental requirements for definition of extracellular vesicles and their functions: a position statement from the International Society for Extracellular Vesicles. J Extracell Vesicles. 2014;3:26913.
36. WitwerKW, Buzás EI, Bemis LT, BoraA, LässerC, Lötvall J,Nolte-'t Hoen EN, Piper MG, Sivaraman S, Skog J, Théry C, Wauben MH, Hochberg F. Standardization of sample collection, isolation and analysis methods in extracellular vesicle research. J Extracell Vesicles. 2013;2:2.
37. Kowal J, Arras G, Colombo M, Jouve M, Morath JP, Primdal-Bengtson B, Dingli F, Loew D. Proteomic comparison defines novel markers to characterize heterogeneous populations of extracellular vesicle subtypes. Proc Natl Acad Sci USA. 2016;113(8):E968-E977.
38. Park F, Russo K, Williams P, Pelosi M, Puddephatt R, Walter M, Leung C, Saaid R, Rawashdeh H, Ogle R, Hyett J. Prediction and prevention of early-onset pre-eclampsia: impact of aspirin after first-trimester screening. Ultrasound Obstet Gynecol. 2015;46(4): 419-423.
39. Rice GE, Scholz-Romero K, Sweeney E, Peiris H, Kobayashi M, Duncombe G, Mitchell MD, Salomon C. The effect of glucose on the release and bioactivity of exosomes from first trimester trophoblast cells. J Clin Endocrinol Metab. 2015;100(10):E1280-E1288.
40. Elfeky O, Longo S, Lai A, Rice GE, Salomon C. Influence of maternal BMI on the exosomal profile during gestation and their role on maternal systemic inflammation. Placenta. 2017;50:60-69.
41. Allen RE, Rogozinska E, Cleverly K, Aquilina J, Thangaratinam S. Abnormal blood biomarkers in early pregnancy are associated with preeclampsia: a meta-analysis. Eur J Obstet Gynecol Reprod Biol. 2014;182:194-201.
42. Giguere Y, Masse J, Theriault S, Bujold E, Lafond J, Rousseau F, Forest JC. Screening for pre-eclampsia early in pregnancy: performance of a multivariable model combining clinical characteristics and biochemical markers. BJOG. 2015;122(3):402-410.
43. Kar M. Role of biomarkers in early detection of preeclampsia. J Clin Diagn Res. 2014;8(4):BE01-BE04.
44. Lalevée S, Lapaire O, Bühler M. miR455 is linked to hypoxia signaling and is deregulated in preeclampsia. Cell Death Dis. 2014; 5:e1408.
45. Korkes HA, Sass N, Moron AF, Ĉamara NO, Bonetti T, Cerdeira AS, Da Silva ID, De Oliveira L. Lipidomic assessment of plasma and placenta of women with early-onset preeclampsia. PLoS One. 2014;9(10):e110747.
46. Valinezhad Orang A, Safaralizadeh R, Kazemzadeh-Bavili M. Mechanisms of miRNA-mediated gene regulation from common downregulation to mRNA-specific upregulation. Int J Genomics. 2014;2014:970607.
47. Sabapatha A, Gercel-Taylor C, Taylor DD. Specific isolation of placenta-derived exosomes from the circulation of pregnant women and their immunoregulatory consequences.AmJ Reprod Immunol. 2006;56(5-6):345-355.
48. Taylor DD, Gercel-Taylor C. MicroRNA signatures of tumorderived exosomes as diagnostic biomarkers of ovarian cancer. Gynecol Oncol. 2008;110(1):13-21.
49. Redman CWG, Sargent IL. Circulating microparticles in normal pregnancy and pre-eclampsia. Placenta. 2008;29(Suppl A):S73-S77.
50. VargasA,Zhou S, Éthier-ChiassonM, FlipoD, Lafond J,GilbertC, Barbeau B. Syncytin proteins incorporated in placenta exosomes are important for cell uptake and show variation in abundance in serum exosomes from patients with preeclampsia. FASEB J. 2014; 28(8):3703-3719.
51. Guibourdenche J, Leguy MC, Tsatsaris V. Biology and markers of preeclampsia. Ann Biol Clin (Paris). 2013;71:79-87.
52. Mincheva-Nilsson L, Baranov V. The role of placental exosomes in reproduction. Am J Reprod Immunol. 2010;63(6):520-533.
53. Fu G, Ye G, Nadeem L, Ji L, Manchanda T,Wang Y, Zhao Y, Qiao J, Wang YL, Lye S, Yang BB, Peng C. MicroRNA-376c impairs transforming growth factor-b and nodal signaling to promote trophoblast cell proliferation and invasion. Hypertension. 2013; 61(4):864-872.
54. Jiang L, Long A, Tan L, Hong M, Wu J, Cai L, Li Q. Elevated microRNA-520g in pre-eclampsia inhibits migration and invasion of trophoblasts. Placenta. 2017;51:70-75.
55. Lala PK, Nandi P. Mechanisms of trophoblast migration, endometrial angiogenesis in preeclampsia: the role of decorin. Cell Adhes Migr. 2016;10(1-2):111-125.
56. Ma X, Wei J, Zhang L, Deng D, Liu L, Mei X, He X, Tian J. miR-486-5p inhibits cell growth of papillary thyroid carcinoma by targeting fibrillin-1. Biomed Pharmacother. 2016;80:220-226.
57. Huang XP, Hou J, Shen XY, Huang CY, Zhang XH, Xie YA, Luo XL. MicroRNA-486-5p, which is downregulated in hepatocellular carcinoma, suppresses tumor growth by targeting PIK3R1. FEBS J. 2015;282(3):579-594.
58. Wang J, Tian X, Han R, Zhang X, Wang X, Shen H, Xue L, Liu Y, Yan X, Shen J, Mannoor K, Deepak J, Donahue JM, Stass SA, Xing L, Jiang F. Downregulation of miR-486-5p contributes to tumor progression and metastasis by targeting protumorigenic ARHGAP5 in lung cancer. Oncogene. 2014;33(9):1181-1189.
59. Poon LC, Kametas NA, Maiz N, Akolekar R, Nicolaides KH. Firsttrimester prediction of hypertensive disorders in pregnancy. Hypertension. 2009;53(5):812-818.